The aggregation of misfolded tau protein is associated with synaptic dysfunction and neuronal loss, and correlates with clinical severity in the Alzheimer’s disease clinical spectrum (Nelson et al., 2012; Spires-Jones and Hyman, 2014). Here, MAPT is linked to Alzheimer disease.